Virtus ETF Advisers LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 189 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$51,616
-59.5%
29,327
-27.8%
0.03%
-58.2%
Q4 2022$127,484
-17.8%
40,600
+28.3%
0.07%
+8.1%
Q3 2022$155,000
+19.2%
31,651
+0.7%
0.06%
+29.2%
Q2 2022$130,000
+6.6%
31,424
+49.8%
0.05%
-12.7%
Q1 2022$122,000
-26.9%
20,983
-5.6%
0.06%
-12.7%
Q4 2021$167,000
+2.5%
22,227
+22.9%
0.06%
-12.5%
Q3 2021$163,000
-28.5%
18,086
-5.0%
0.07%
-23.4%
Q2 2021$228,000
-20.8%
19,037
-17.1%
0.09%
-23.0%
Q1 2021$288,000
-18.2%
22,950
+1.8%
0.12%
-16.4%
Q4 2020$352,000
+32.8%
22,554
-19.6%
0.15%
+5.0%
Q3 2020$265,000
-7.3%
28,049
-12.0%
0.14%
+3.0%
Q2 2020$286,000
+6.3%
31,864
-24.6%
0.14%
+21.6%
Q1 2020$269,000
-33.6%
42,254
-12.7%
0.11%
+68.2%
Q4 2019$405,000
+64.6%
48,408
+78.4%
0.07%
+32.0%
Q3 2019$246,000
-20.1%
27,131
-5.3%
0.05%
-23.1%
Q2 2019$308,000
+2.7%
28,643
+9.7%
0.06%
+27.5%
Q4 2018$300,000
-41.3%
26,120
-13.3%
0.05%
-3.8%
Q3 2018$511,000
-30.4%
30,135
-41.7%
0.05%
-91.8%
Q2 2018$734,000
-16.9%
51,691
+11.3%
0.65%
-15.3%
Q1 2018$883,000
+149.4%
46,449
+115.1%
0.77%
+72.5%
Q4 2017$354,000
-46.4%
21,591
-50.9%
0.44%
+398.9%
Q3 2017$660,000
+87.5%
43,982
+10.1%
0.09%
+67.9%
Q2 2017$352,000
+84.3%
39,959
-3.1%
0.05%
-42.4%
Q3 2016$191,000
-20.1%
41,2490.0%0.09%
-48.0%
Q2 2016$239,000
+35.8%
41,249
+41.9%
0.18%
-26.9%
Q1 2016$176,000
-37.6%
29,061
-5.8%
0.24%
-68.7%
Q4 2015$282,00030,8470.77%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Lombard Odier Asset Management (Switzerland) SA 1,539,994$11,550,0000.74%
Golden State Equity Partners 143,768$1,078,0000.54%
Rhenman & Partners Asset Management AB 765,000$5,975,0000.40%
WASATCH ADVISORS LP 10,960,982$82,207,0000.34%
KLK CAPITAL MANAGEMENT LLC 44,323$332,0000.32%
EMC Capital Management 61,394$460,0000.25%
Rokos Capital Management LLP 539,860$4,108,0000.25%
Long Focus Capital Management, LLC 245,000$1,838,0000.24%
Vanguard Capital Wealth Advisors 33,380$250,0000.18%
Fort Sheridan Advisors LLC 74,898$562,0000.16%
View complete list of SANGAMO THERAPEUTICS INC shareholders